Bisoprolol Transdermal Patch for Perioperative Care of Non-cardiac Surgery in Patients with Hypertrophic Obstructive Cardiomyopathy
Not Applicable
- Conditions
- Hypertrophic obstructive cardiomyopathy
- Registration Number
- JPRN-UMIN000036703
- Lead Sponsor
- ippon Medial School Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded patients who exhibited only sigmoid septum but without significant hypertrophy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemodynamic and echocardiographic features before and after patients switched from oral bisoprolol to transdermal patch therapy or started transdermal patch therapy as a new beta blocker medication
- Secondary Outcome Measures
Name Time Method cardiovascular complications (all cause death, cardiac death, heart failure, ventricular tachycardia, and ventricular fibrillation) in the perioperative period